Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Does the presence of a BRCA 1/2 mutation affect your recommendation for post-mastectomy RT in patients with pT1-2, N0 disease?
Answer from: Radiation Oncologist at Community Practice
It doesn’t influence RT decision.
Sign In
or
Register
to read more
11230
Related Questions
Do you recommend high ozonated oil for radiation dermatitis?
Would you offer PMRT to a patient with potential metastatic disease?
Would you consider APBI in a patient who meets all criteria but has high-risk genomic testing and is not receiving chemotherapy?
How do you manage symptomatic fat necrosis following adjuvant breast radiotherapy?
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
How do you advise women to manage wound care for breast brachytherapy needle sites for long term cosmetic outcomes?
Would you offer prone APBI with IMRT/VMAT?
How would you approach a patient with a 12 mm recurrence of the left implant-based breast reconstruction 17 years after her initial diagnosis?
Is there additional concern for late cardiac toxicity when using ultrahypofractionated breast radiation protocols, given that the BED to the heart is higher?
Do you ever treat cervical nodes above the standard supraclavicular field for breast cancer patients?